tradingkey.logo
tradingkey.logo

RadNet Inc

RDNT
View Detailed Chart
56.150USD
-3.260-5.49%
Close 03/27, 16:00ETQuotes delayed by 15 min
2.15BMarket Cap
LossP/E TTM

RadNet Inc

56.150
-3.260-5.49%
Intraday
1m
30m
1h
D
W
M
D

Today

-5.49%

5 Days

-8.68%

1 Month

-19.57%

6 Months

-26.03%

Year to Date

-21.30%

1 Year

+10.82%

View Detailed Chart

TradingKey Stock Score of RadNet Inc

Currency: USD Updated: 2026-03-27

Key Insights

RadNet Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 46 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 92.38.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

RadNet Inc's Score

Industry at a Glance

Industry Ranking
46 / 75
Overall Ranking
224 / 4542
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

RadNet Inc Highlights

StrengthsRisks
RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.20% year-on-year.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -226.35, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 74.59M shares, decreasing 2.10% quarter-over-quarter.
Held by Frank Sands
Star Investor Frank Sands holds 9.06K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.56.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
92.375
Target Price
+54.29%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

RadNet Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

RadNet Inc Info

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.
Ticker SymbolRDNT
CompanyRadNet Inc
CEOWesdorp (Cornelis)
Websitehttps://www.radnet.com/
KeyAI